Moderna advances two vax candidates against Omicron variants
The company is one of a number of vaccine makers developing new shots to tackle BA.4 and BA.5.
The company is one of a number of vaccine makers developing new shots to tackle BA.4 and BA.5.
Turns out chronic pain MedsCheck is an intervention few pharmacists want to deliver, and few patients want to be involved with. Another multi-million dollar pharmacy…
SA researchers are behind the new DNA vaccine that targets the Omicron variant.
he updated vaccine formulation raises antibodies eightfold against the COVID-19 variant, according to preliminary data released by the company.
…A Canadian doctor has shared the case of a patient who developed severe electrolyte imbalance after being continuously prescribed the drugs.
Many cancer treatments are notoriously savage on the body. Drugs often attack both healthy cells and tumour cells, causing a plethora of side effects. Immunotherapies that…
Dr Nicole Higgins, a former board director on the network, says it has become entangled in a web of 'influential organisations, institutions and re…
This comes as experts rule out routine use of sotrovimab against circulating subvariants and a new hybrid variant, Deltacron, emerges in Australia.…
Medicines expert Dr Geraldine Moses (PhD) labelled the decision 'ridiculous'.
Early intervention with the much-touted drug fails to keep high-risk patients out of hospital or shorten recovery times,…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.